BEHIND EVERY DOSE OF PERSONALIZED MEDICINE IS A COMPLICATED NETWORK THAT SUPPORTS THE COLLECTION, PROCESSING, AND PATIENT CARE THAT GOES INTO ADVANCED THERAPIES. Advanced therapies hold transformative ...
1. Introduction Cryopreservation is a critical component in the storage of cell-based therapies, ensuring product stability, cell viability, and product efficacy. As the cell and gene therapy ...
Unlock seamless, end-to-end automated cell manufacturing At Miltenyi Biotec, we’re prepared to revolutionize your cell manufacturing workflow with our cutting-edge CliniMACS Formulation Unit. Integrated ...
As cell and gene therapies, drug discovery, and fundamental stem cell research continue to advance, the need for scalable, reproducible, and efficient differentiation of human pluripotent stem cells (hPSCs) ...
Azenta Life Sciences has officially opened its state-of-the-art biorepository facility in the Greater Boston area, designed to serve the unique storage and management needs of the biotech and life sciences ...
Rebecca Ihilchik, MA Stacey Johnson, MSc CCRM The discourse around artificial intelligence (AI) is seemingly everywhere nowadays. Increasingly influential in our everyday lives, AI has transformed ...
STEMCELL Technologies Human hematopoietic cells are generated in waves during development. The first wave produces mainly primitive blood cells that serve the early needs of the growing embryo. Later ...
New Facilities in Houston, Tx and Villers-le-Bouillet, Belgium Strengthen Cryoport Systems’ Global Leadership in Temperature-Controlled Supply Chain Services (Houston, Tx, USA and Villers-le-Bouillet, ...
By Olga Bukatova, Associate Director of Business Development, CGT, Azenta Life Sciences With a projected rate of 10-20 product approvals per year, the global cell and gene therapy (CGT) industry ...
Article Provided by Miltenyi Biotec Despite a turbulent market environment, the cell and gene therapy (CGT) field continues to advance, with several groundbreaking therapies slated to receive FDA approval ...
Erica Waller Senior Product Manager Cryo Automation and Stores Azenta Life Sciences Burlington, MA, USA Cryopreservation, the process of preserving cells, tissues, and organs at extremely low temperatures, ...
Sponsored Article provided by Akron Biotech Robert Margolin Vice President, Commercial Akron BioProducts Ezequiel Zylberberg Vice President, Corporate Development Akron BioProducts ...
Pittsburgh, Pa., August 23, 2024 — Cook MyoSite announced that the first participant was treated in the DigniFI Study, a two-stage, randomized, controlled Phase III trial comparing the safety and efficacy ...
by Fajar Dumadi, BSc Regulatory Program Specialist ISCT Head Office This draft guidance provides recommendations for developing a science- and risk-based strategy to help assure the potency of a human ...
Sponsored Content from Stemcell Technologies The cell and gene therapy field is rapidly advancing as shown by the growing number of clinical trials and regulatory-approved therapies.¹ As the ...
by Laine Bodnar Senior Manager Communications CCRM Whether you’ve visited Canada or not, you probably know that it’s famous for beautiful scenery, maple syrup and ice hockey. Canada is also where ...
by Katy Spink, Ph.D., Dark Horse Consulting Group’s COO & MP Katy Spink Presents at an Internal DHC Retreat in 2018 Full disclosure: my CGT career began just over 20 years ago when ...
by Dr. Steve Oh, PhD Independent Cell Therapy Leader Singapore A webinar presented by the ISCT Process Development and Manufacturing (PDM) Committee Particulates are ...
ISCT’s Process Development & Manufacturing Committee invites you to take part in a survey to determine the current state of Process Analytical Technologies (PAT) in Cell & Gene Therapy (C>) Manufacturing. ...
Sponsored content provided by Stemcell Technologies ISCT Industry Member Human pluripotent stem cells (hPSCs) can be a powerful tool in your cell and gene therapy development toolkit. ...
William Watt, PhD President, Astellas Venture Management LLC Please introduce yourself. What is your background and experience in cell and gene therapy? My basic training was as ...
by Shannon Eaker, PhD, Chief Technology Officer at Xcell Biosciences * Dominic Clarke, PhD, Consultant & Chief Strategy Officer at Orange County Bio * *Representing the International ...
Miltenyi Bioindustry is a global CDMO service provider specializing in cell and gene therapy. With more than 25 years of experience, we offer comprehensive process development and manufacturing services ...
Proprietary Platform Moves Promising Cell Therapy Candidates from Contract to Clinic in Six Months NEWARK, NJ, June 1, 2023 – BioCentriq®, a strategic CDMO (contract development and manufacturing ...
Monday, January 9, 2023 (Toronto, ON) – Viral vectors are critical components in the manufacturing of cell and gene therapies, but their production is currently a key bottleneck and cost driver. CCRM, ...
Recently, Eutilex, a partner of GenScript ProBio, announced MFDS clearance of its hepatocellular carcinoma clinical trial application for innovative CAR-T program (EU307). GenScript ProBio extends congratulations ...
Sponsored Article Provided by Thermo Fisher Thermo Fisher Scientific Patheon Translational Services facility in San Diego The advanced therapies field is expected to grow at an ...
OmniaBio Expands Manufacturing Footprint with Second Hamilton Location January 24, 2023 (Hamilton, ON) – OmniaBio Inc. has expanded its footprint by adding a new process and analytical development ...
MicrofluidX and CCRM Partner on End-to-End Bioprocessing of CAR-T Cell Therapies Stevenage, UK, and Toronto, Canada, January 11, 2023— MicrofluidX (MFX), a UK-based provider of next-generation bioreactors ...
BioCentriq, Inc.—a New Jersey-based, cell and gene therapy contract development and manufacturing organization (CDMO)—announced today that they've completed a study designed to test transfection of T-cells ...
Sponsored article provided by Santen Founded in Japan over a century ago, Santen has been contributing to people’s eye health for the past 130 years. During this time the company has expanded to ...
Members in the News: Minaris Regenerative Medicine Minaris Regenerative Medicine GmbH and Mendus AB extend manufacturing partnership to large-scale production of DCP-001, an experimental allogeneic ...
Sponsored article provided by CCRM Architect’s rendering of OmniaBio facility under construction in Hamilton, Ontario Globally, the race is on to bring facilities online that ...
Meet the Investor Brought to you by the ISCT Business Development & Finance Committee Bryan Poltilove Operating Partner BroadOak Capital Partners As Operating ...
ISCT Asia Pacific (APAC) Industry Committee Furthering ISCT’s role in facilitating global and regional strategic partnerships, in March 2022, ISCT Industry Leadership launched the Asia Pacific ...
Members in the News: Ori Biotech and CTMC partner to accelerate novel cell therapy delivery London, UK, and Houston, TX, US, September 13, 2022 – Ori Biotech (Ori), a leader in cell and gene ...
Industry Members in the News Funding from Ontario government launches OmniaBio Inc. OmniaBio Inc’s new facility will be the largest CDMO in Canada for the manufacture of CGTs ...
Meet the Investor Segment Brought to you by the ISCT Business Development & Finance Committee Jonathan Yeh, PhD Partner & Co-Founder Saisei Ventures Canada ...
Publication from ISCT Process Development and Manufacturing Committee Impact considerations of post-production processes on cell and gene drug products PUBLISHED IN CYTOTHERAPY - VOLUME 24, ISSUE ...
First 3 Webinars from the Cryopreservation Webinar Series Available Online Brought to you by the ISCT Process & Product Development Committee Part 1: An Appreciation of Cryopreservation and ...